Skip to main content

Advertisement

SpringerLink
Log in

Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up (BERVOLT study: bevacizumab for RVO long-term follow-up)

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kornhauser T, Schwartz R, Goldstein M, Neudorfer M, Lowenstein A, Barak A (2015) Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up). Graefes Arch Clin Exp Ophthalmol. doi:10.1007/s00417-01-3130-z

    Google Scholar 

  2. Epstein DLJ, Algvere PV, von Wendt G, Seregard S, Kvanta A (2012) Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study. Ophthalmology 119:1184–1189

    Article  PubMed  Google Scholar 

  3. Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, Murahashi WY, Rubio RG (2011) Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 118:2041–2049

    Article  PubMed  Google Scholar 

  4. Brown DM, Wykoff CC, Wong TP, Mariani AF, Croft DE, Schuetzle KL (2014) Ranibizumab in preproliferative (ischemic) central retinal vein occlusion. The rubeosis and-VEGF (RAVE) trial. Retina 34:1728–1735

    Article  CAS  PubMed  Google Scholar 

  5. Călugăru D, Călugăru M (2015) Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. J Ocul Pharmacol Ther 31:78–86

    Article  PubMed  Google Scholar 

  6. Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS, Marcus DM, Feiner L, Patel A (2014) Lont-term outcomes in patients with retinal vein occlusion treated with ranibizumab. The RETAIN study. Ophthalmology 121:209–219

    Article  PubMed  Google Scholar 

  7. Heier JS, Clark WL, Boyer DS, Brown DM, Vitti R, Berliner AJ, Kazmi H, Ma Y, Stemper B, Zeitz O, Sandbrink R, Haller JA (2014) Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion. Two-year results from the COPERNICUS study. Ophthalmology 121:1414–1420

    Article  PubMed  Google Scholar 

  8. Ogura Y, Roider J, Korobelnik JF, Holz FG, Simader C, Schmidt-Erfurth U, Vitti R, Berliner AJ, Hiemeyer F, Stemper B, Zeitz O, Sandbrink R (2014) Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion. 18-month results of the phase 3 GALILEO study. Am J Ophthalmol 158:1032–1038

    Article  CAS  PubMed  Google Scholar 

  9. Călugăru M (1987) Les resultats d’une enquete sur la survenue du glaucome neovasculaire après occlusion de la veine centrale de la retine. J Fr Ophtalmol 10:479–483

    PubMed  Google Scholar 

  10. Chan A, Duker JS, Ko T, Fujimoto JG, Schuman JS (2006) Normal macular thickness measurements in healthy eyes using status optical coherence tomography. Arch Ophthalmol 124:193–198

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest, and have no financial disclosures to report. Both authors (D.C. and M.C.) were involved in the design and conduct of the study, the collection, management, analysis and interpretation of the data, and the preparation, review and approval of the manuscript.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Medicine Cluj-Napoca, Cluj-Napoca, Romania

    Dan Călugăru & Mihai Călugăru

Authors
  1. Dan Călugăru
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mihai Călugăru
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mihai Călugăru.

Ethics declarations

Disclosure

The authors have full control of the primary data and have agreed to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data upon request.

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Călugăru, D., Călugăru, M. Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up (BERVOLT study: bevacizumab for RVO long-term follow-up). Graefes Arch Clin Exp Ophthalmol 254, 1023–1024 (2016). https://doi.org/10.1007/s00417-015-3219-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-015-3219-4

Keywords

Search

Navigation